Press releases

  21/04/2021 08:00
|

Quantum Genomics will Present Top-line Results from its QUORUM study of Firibastat in Heart Failure post Myocardial Infarction at the European Society of Cardiology (ESC) Meeting

  20/04/2021 08:00
|

Quantum Genomics announces the end of its collaboration with Chinese Pharma Qilu in the development and commercialization of firibastat in China

  25/03/2021 18:00
|

Quantum Genomics Reports Full Year 2020 Operating and Financial Results

  09/02/2021 18:00
|

Orient EuroPharma Acquires Equity Stake in Quantum Genomics

  18/01/2021 08:00
|

Quantum Genomics Launches Phase III Pivotal REFRESH Study in Difficult-to-treat/Resistant Hypertension with Once-a-day Formulation of Firibastat